Expired activity
Please go to the PowerPak homepage and select a course.

Pharmacy Practice in the Management of VOD/SOS:
Developing Optimal Care Models and Modern Therapeutic Arsenals

Release Date: November 10, 2017
Expiration Date: November 09, 2018 PeerView inReview

Time to Complete Activity: 30 minutes
Media: Enduring Material

Activity Description and Educational Objectives

In this activity, an expert in VOD/SOS discusses the pharmacist's perspective on optimal care models and the use of modern therapeutic arsenals for the recognition and management of VOD/SOS in cancer patients undergoing stem cell transplantation.

Upon completion of this activity, participants will be able to:

  • Cite the medical and financial burden of untreated or inadequately treated VOD/SOS, including VOD with MOD/MOF
  • Summarize pre-transplant therapies that may elevate the risk for VOD/SOS in cancer patients
  • Select therapeutic options for VOD/SOS prevention and treatment based on the latest clinical evidence
  • Discuss dosing and safety considerations with conventional and novel options for VOD/SOS prevention or treatment

Target Audience

This activity has been designed to meet the educational needs of pharmacists and other clinicians involved in the care of transplant-eligible cancer patients at risk for VOD/SOS.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CPE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Faculty & Disclosure/Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CPE activity during the past 12 months.

Course Director

Alex Ganetsky, PharmD, BCOP
Clinical Pharmacy Specialist–Hematology/BMT
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

Alex Ganetsky, PharmD, BCOP, has a financial interest/relationship or affiliation in the form of:
Speakers Bureau participant with Amgen Inc. and Incyte Corporation.
Advisory Board for Jazz Pharmaceuticals, Inc.
Alex Ganetsky, PharmD, BCOP, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

CPE Reviewer

Nancy Nesser, JD, PharmD
Oklahoma Health Care Authority
Oklahoma City, Oklahoma

Nancy Nesser, JD, PharmD, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.


The information provided at this CPE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support


The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this knowledge-based activity provides for 0.5 contact hours (0.05 CEUs) of continuing pharmacy education credit. The Universal Activity Number for this activity is 0468-9999-17-012-H01-P.


This CPE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.


This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer's product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CPE Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

Copyright © 2000-2017, PeerView